An examination of multiple explanations for secondary hyperparathyroidism

被引:1
|
作者
Phelps, Kenneth R. [1 ,2 ]
Mason, Darius L. [3 ,4 ]
机构
[1] Stratton Vet Affairs Med Ctr, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Methodist LeBonheur Healthcare, Memphis, TN USA
[4] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
关键词
secondary hyperparathyroidism; chronic kidney disease; phosphate; vitamin D; fibroblast growth factor 23; PARATHYROID-HORMONE; VITAMIN-D; KIDNEY; PHOSPHATE; PHOSPHORUS; CALCIUM; PTH; FGF23; 1,25-DIHYDROXYVITAMIN-D; PATHOGENESIS;
D O I
10.5414/CN110043
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Seven theories address the evolution of secondary hyperparathyroidism (SHPT) as chronic kidney disease (CKD) progresses. The tradeoff-in-the-nephron hypothesis states that the plasma parathyroid hormone ([PTH]) concentration rises because an increased phosphate concentration in the cortical distal nephron ([P](CDN)) reduces the ionized calcium concentration in that segment. In the present study, we compared this hypothesis to its predecessors. Materials and methods: We studied 30 patients with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73m(2) (mean 29.5). To examine historic theories, we performed regressions of [PTH] on plasma concentrations of ionized calcium, phosphorus, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and fibroblast growth factor 23, and on calcium excreted per volume of filtrate (E-Ca/C-cr). To assess the tradeoff-in-the-nephron hypothesis, we examined regressions of [PTH] on 100/eGFR and phosphorus excreted per volume of filtrate (E-P/C-cr). Results: Regressions pertinent to historic theories yielded significant direct relationships between [PTH] and both E-Ca/C-cr and [FGF23], but neither association supported the theory to which it pertained. [PTH] varied directly with 100/eGFR and with E-P/C-cr, a surrogate for [P](CDN). E-P/C-cr correlated strongly with 100/eGFR. Conclusions: The only theory of SHPT that our data support is the tradeoff-in-the-nephron hypothesis. Other theories are not supported.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [1] Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease
    Wei, Yudan
    Lin, Jing
    Yang, Fan
    Li, Xiujiang
    Hou, Yue
    Lu, Ronghua
    Shi, Xiaonv
    Liu, Zhi
    Du, Yujun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (02) : 1206 - 1212
  • [2] Cellular and molecular mechanisms of secondary hyperparathyroidism
    Silver, J
    Levi, R
    CLINICAL NEPHROLOGY, 2005, 63 (02) : 119 - 126
  • [3] The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism
    Alfieri, Carlo
    Regalia, Anna
    Zanoni, Francesca
    Vettoretti, Simone
    Cozzolino, Mario
    Messa, Piergiorgio
    BLOOD PURIFICATION, 2019, 47 (1-3) : 37 - 44
  • [4] Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism
    Phelps, Kenneth R.
    Stote, Kim S.
    Mason, Darius
    CLINICAL NEPHROLOGY, 2014, 82 (03) : 191 - 201
  • [5] Pathogenesis of secondary hyperparathyroidism
    Cozzolino, Mario
    Pasho, Sabina
    Fallabrino, Giuditta
    Olivi, Laura
    Gallieni, Maurizio
    Brancaccio, Diego
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (02) : 75 - 80
  • [6] Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients
    Torres, P. A. Urena
    Bover, J.
    Cohen-Solal, M.
    DRUGS OF TODAY, 2017, 53 (09) : 489 - 500
  • [7] Secondary Hyperparathyroidism: Pathophysiology and Treatment
    Saliba, Wissam
    El-Haddad, Boutros
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2009, 22 (05) : 574 - 581
  • [8] Molecular mechanisms of secondary hyperparathyroidism
    Silver, J
    Kilav, R
    Sela-Brown, A
    Naveh-Many, T
    PEDIATRIC NEPHROLOGY, 2000, 14 (07) : 626 - 628
  • [9] German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)
    Reichel, H.
    Braun, J.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (04) : 123 - 128
  • [10] Mechanisms of secondary hyperparathyroidism
    Silver, J
    Kilav, R
    Naveh-Many, T
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (03) : F367 - F376